Related references
Note: Only part of the references are listed.Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans
Adil Mardinoglu et al.
CELL METABOLISM (2018)
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
Varman T. Samuel et al.
CELL METABOLISM (2018)
Determinants of fibrosis progression and regression in NASH
Detlef Schuppan et al.
JOURNAL OF HEPATOLOGY (2018)
Systems biology in hepatology: approaches and applications
Adil Mardinoglu et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Broad Views of Non-alcoholic Fatty Liver Disease
Adil Mardinoglu et al.
CELL SYSTEMS (2018)
Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD)
Cathrin Sellmann et al.
EUROPEAN JOURNAL OF NUTRITION (2017)
Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD
Adil Mardinoglu et al.
MOLECULAR SYSTEMS BIOLOGY (2017)
An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD plus levels in healthy volunteers
Sophia E. Airhart et al.
PLOS ONE (2017)
Improving the economics of NASH/NAFLD treatment through the use of systems biology
Jim Bosley et al.
DRUG DISCOVERY TODAY (2017)
Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin Resistance
Sunjae Lee et al.
CELL METABOLISM (2016)
Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults
M. Monseu et al.
DIABETES & METABOLISM (2016)
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
Sven M. Francque et al.
JOURNAL OF HEPATOLOGY (2016)
Phenotypic and genetic variance: a systems approach to the liver
Adil Mardinoglu et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease
Tuulia Hyotylainen et al.
NATURE COMMUNICATIONS (2016)
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Samuel A. J. Trammell et al.
NATURE COMMUNICATIONS (2016)
Associations of gut-floradependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
Yu-ming Chen et al.
SCIENTIFIC REPORTS (2016)
Fibroblast growth factor 21 reflects liver fat accumulation and dysregulation of signalling pathways in the liver of C57BL/6J mice
Fenni Rusli et al.
SCIENTIFIC REPORTS (2016)
New paradigms for metabolic modeling of human cells
Adil Mardinoglul et al.
CURRENT OPINION IN BIOTECHNOLOGY (2015)
The gut microbiota modulates host amino acid and glutathione metabolism in mice
Adil Mardinoglu et al.
MOLECULAR SYSTEMS BIOLOGY (2015)
De novo lipogenesis in metabolic homeostasis: More friend than foe?
Giovanni Solinas et al.
MOLECULAR METABOLISM (2015)
Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease
Adil Mardinoglu et al.
NATURE COMMUNICATIONS (2014)
Non-alcoholic steatohepatitis: The role of oxidized low-density lipoproteins
Sofie M. A. Walenbergh et al.
JOURNAL OF HEPATOLOGY (2013)
Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology
Huating Li et al.
FRONTIERS OF MEDICINE (2013)
Serum TGF-β, Serum MMP-1, and HOMA-IR as Non-Invasive Predictors of Fibrosis in Egyptian Patients with NAFLD
Adel A. Mahmoud et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2012)
Deficiency for Costimulatory Receptor 4-1BB Protects Against Obesity-Induced Inflammation and Metabolic Disorders
Chu-Sook Kim et al.
DIABETES (2011)
Potential involvement of CCL23 in atherosclerotic lesion formation/progression by the enhancement of chemotaxis, adhesion molecule expression, and MMP-2 release from monocytes
Chu-Sook Kim et al.
INFLAMMATION RESEARCH (2011)
Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1
Kevin Garofalo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease
Takhar Kasumov et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Jody Dushay et al.
GASTROENTEROLOGY (2010)
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
Huating Li et al.
JOURNAL OF HEPATOLOGY (2010)
Disposition of D-serine in healthy adults
Guochuan E. Tsai et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Risk assessment for carnitine
John N. Hathcock et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2006)
Dissecting the energy needs of the body
SA McClave et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2001)
Share Paper
